FICHA DEL DOCTOR

Dr. Emilio Montserrat (web)

Actividad docente

Profesores

Professor en el Departament de Medicina

Facultat de Medicina. Universitat de Barcelona.

Publicaciones

Revistas científicas

Chronic lymphocytic leukemia: new concepts for future therapy (ver web)

(coautor junto aWierda WG, Chiorazzi N, Dearden C, Brown JR,  Shpall E, Stilgenbauer S, Muneer S, Grever M.) Clin Lymphoma Myeloma Leuk. 2010 Oct;10(5):369-78.

Autoimmune cytopenia in chronic lymphocytic leukemia: prevalence, clinical associations, and prognostic significance (ver web)

(coautor junto a Moreno C, Hodgson K, Ferrer G, Elena M, Filella X, Pereira A, Baumann T) Blood. 2010 Dec 2;116(23):4771-6. Epub 2010 Aug 24.

Advances in biology and therapy of chronic lymphocytic leukemia. Preface (ver web)

Best Pract Res Clin Haematol. 2010 Mar;23(1):1-2. No abstract available.

Verification that common variation at 2q37.1, 6p25.3, 11q24.1, 15q23, and 19q13.32 influences chronic lymphocytic leukaemia risk (ver web)

(coautor junto a Crowther-Swanepoel D, Mansouri M, Enjuanes A, Vega A, Smedby KE, Ruiz-Ponte C, Jurlander J, Juliusson G, Catovsky D, Campo E, Carracedo A, Rosenquist R, Houlston RS) Br J Haematol. 2010 Aug;150(4):473-9. Epub 2010 Jun 10.

Clinico-biological characterization and outcome of primary nodal and extranodal diffuse large B-cell lymphoma in the rituximab era (ver web)

(coautor junto a  Gutiérrez-García G, Colomo L, Villamor N, Arenillas L, Martínez A, Cardesa T, García-Herrera A, Setoain X, Rodríguez S, Ghita G, Abrisqueta P, Giné E, Bosch F, Campo E, López-Guillermo A.) Leuk Lymphoma. 2010 Jul;51(7):1225-32.

Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia ("accelerated" chronic lymphocytic leukemia) with aggressive clinical behavior (ver web)

(coautor junto a  Giné E, Martinez A, Villamor N, López-Guillermo A, Camos M, Martinez D, Esteve J, Calvo X, Muntañola A, Abrisqueta P, Rozman M, Rozman C, Bosch F, Campo E). Haematologica. 2010 Sep;95(9):1526-33. Epub 2010 Apr 26.

Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk (ver web)

(coautor junto a Crowther-Swanepoel D, Broderick P, Di Bernardo MC, Dobbins SE, Torres M, Mansouri M, Ruiz-Ponte C, Enjuanes A, Rosenquist R, Carracedo A, Jurlander J, Campo E, Juliusson G, Smedby KE, Dyer MJ, Matutes E, Dearden C, Sunter NJ, Hall AG, Mainou-Fowler T, Jackson GH, Summerfield G, Harris RJ, Pettitt AR, Allsup DJ, Bailey JR, Pratt G, Pepper C, Fegan C, Parker A, Oscier D, Allan JM, Catovsky D, Houlston RS). Nat Genet. 2010 Feb;42(2):132-6. Epub 2010 Jan 10.

Genetic lesions in chronic lymphocytic leukemia: what's ready for prime time use? (ver web)

(coautor junto a Moreno C) Haematologica. 2010 Jan;95(1):12-5. No abstract available.

Salvage chemotherapy with alternating MINE-ESHAP regimen in relapsed or refractory Hodgkin's lymphoma followed by autologous stem-cell transplantation (ver web)

(coautor junto a  Fernández de Larrea C, Martínez C, Gaya A, López-Guillermo A, Rovira M, Fernández-Avilés F, Lozano M, Bosch F, Esteve J, Nomdedeu B, Montserrat E, Carreras E.) Ann Oncol. 2010 Jun;21(6):1211-6. Epub 2009 Nov 4.